MSInsight

Who are we

MSInsight is a start-up specializing in the detection of biomarkers to predict cancer patients' response to precision treatments. Its software, MSIcare, uses next-generation sequencing (NGS) to detect microsatellite instability in solid tumors. This technology assesses the functionality of the DNA repair system in tumor cells, helping determine the potential effectiveness of treatments. By enabling patients to access more personalized and tailored therapies, MSInsight contributes to improved health outcomes.